Dáil Éireann Debate, Wednesday - 24 March 2021
1328. Deputy David Cullinane asked the Minister for Health the findings of the 2019 review on the governance structures in relation to the HSE drug reimbursement process by a company (details supplied); if he will publish the review in full; and if he will make a statement on the matter. [13947/21]
View answerIn 2019, following a tender by the Office of Government Procurement, Mazars conducted a review of the governance structures around the HSE's drug reimbursement process. The report was submitted to my Department in January 2020.
The review made recommendations in respect of the HSE’s systems, structures, processes, governance arrangements and use of specialist resources in respect of the drug reimbursement process.
The report was under consideration by officials earlier last year, however the focus of the Department of Health changed to the immediate public health considerations of the COVID-19 pandemic and the preservation of life. This meant that this work stream was temporarily suspended to reallocate resources to support essential services.
My Department aims to complete its consideration of the report’s recommendations in the near future.
